Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 · kind B2 · utility
8Cited by
58References
11Claims
0Family size
Inventors
Key dates
| Filing date | Oct 11, 2006 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Oct 11, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Presently described are methods of administration and associated treatment of one or more ocular conditions using cyclosporine, or an analog or derivative thereof. The ocular conditions can be a result of treatment using other therapeutic agents, such as chemotherapy agents, antiviral agents and immunomodulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.